Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Journal of Medicinal Chemistry Chinese GLP 1, Cagrilintide Used by Americans to Lose Weight Cheaply
By Reuters 27 Jun, 2025< small> GOLDSEA Asian American Daily